HP
HealthInvest Partners Portfolio holdings
AUM $234M
1-Year Return
10.88%
This Quarter Return
+5.6%
1 Year Return
+10.88%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$140M
AUM Growth
+$39.8M
(+40%)
Cap. Flow
+$34.1M
Cap. Flow
% of AUM
24.33%
Top 10 Holdings %
Top 10 Hldgs %
73.07%
Holding
23
New
5
Increased
9
Reduced
3
Closed
5
Top Buys
| 1 |
CFN
CAREFUSION CORPORATION
CFN
|
+$8.43M |
| 2 |
MGLN
Magellan Health Services, Inc.
MGLN
|
+$8.33M |
| 3 |
AET
Aetna Inc
AET
|
+$8.31M |
| 4 |
Cardinal Health
CAH
|
+$8.31M |
| 5 |
GTS
Triple-S Management Corporation
GTS
|
+$5.72M |
Top Sells
| 1 |
Myriad Genetics
MYGN
|
+$7.94M |
| 2 |
McKesson
MCK
|
+$6.8M |
| 3 |
ESRX
Express Scripts Holding Company
ESRX
|
+$4.59M |
| 4 |
BCR
CR Bard Inc.
BCR
|
+$2.95M |
| 5 |
CUTR
Cutera, Inc.
CUTR
|
+$877K |
Sector Composition
| 1 | Healthcare | 79.98% |
| 2 | Financials | 10% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Charles River Laboratories
CRL
$7.48B
| $13M | 9.25% |
215,013
-3,887
| -2% | -$235K |
|
|
AIQ
2
DELISTED
Alliance Healthcare Services, Inc.
AIQ
| $12.5M | 8.9% |
372,276
+90,533
| +32% | +$3.04M |
|
3
Hologic
HOLX
$14.1B
| $12M | 8.53% |
556,920
+251,970
| +83% | +$5.42M |
|
4
Medtronic
MDT
$121B
| $11.6M | 8.25% |
188,200
-9,700
| -5% | -$597K |
|
5
Elevance Health
ELV
$69.4B
| $11.3M | 8.07% |
113,800
+38,300
| +51% | +$3.81M |
|
|
HRC
6
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $8.56M | 6.1% |
222,200
+60,000
| +37% | +$2.31M |
|
|
LPNT
7
DELISTED
LifePoint Health, Inc.
LPNT
| $8.55M | 6.09% |
156,700
+25,000
| +19% | +$1.36M |
|
|
CFN
8
DELISTED
CAREFUSION CORPORATION
CFN
| $8.43M | 6.01% |
+209,600
| New | +$8.43M |
|
|
MGLN
9
DELISTED
Magellan Health Services, Inc.
MGLN
| $8.33M | 5.94% |
+140,375
| New | +$8.33M |
|
|
AET
10
DELISTED
Aetna Inc
AET
| $8.31M | 5.93% |
+110,900
| New | +$8.31M |
|
|
11
Cardinal Health
CAH
$35.6B
| $8.31M | 5.92% |
+118,700
| New | +$8.31M |
|
|
ESRX
12
DELISTED
Express Scripts Holding Company
ESRX
| $8.07M | 5.75% |
107,500
-61,100
| -36% | -$4.59M |
|
|
GTS
13
DELISTED
Triple-S Management Corporation
GTS
| $5.72M | 4.08% |
+372,801
| New | +$5.72M |
|
|
THOR
14
DELISTED
THORATEC CORPORATION
THOR
| $5.49M | 3.91% |
153,366
+55,231
| +56% | +$1.98M |
|
|
SKH
15
DELISTED
SKILLED HEALTHCARE GROUP, INC. CLASS A COM STK
SKH
| $4.82M | 3.44% |
915,365
+147,588
| +19% | +$778K |
|
16
Artivion
AORT
$1.87B
| $4.7M | 3.35% |
471,603
+93,603
| +25% | +$932K |
|
17
ImmuCell
ICCC
$52.4M
| $389K | 0.28% |
80,946
+11,338
| +16% | +$54.5K |
|
|
CEMI
18
DELISTED
Chembio diagnostics, Inc.
CEMI
| $288K | 0.21% |
83,372
| – | – |
|
|
BCR
19
DELISTED
CR Bard Inc.
BCR
| – | – |
-22,000
| Closed | -$2.95M |
|
|
20
McKesson
MCK
$86.6B
| – | – |
-42,100
| Closed | -$6.8M |
|
|
21
Myriad Genetics
MYGN
$692M
| – | – |
-378,200
| Closed | -$7.94M |
|
|
CUTR
22
DELISTED
Cutera, Inc.
CUTR
| – | – |
-86,168
| Closed | -$877K |
|
|
SCLN
23
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| – | – |
-135,000
| Closed | -$680K |
|